Mr. Graham Farrell reports

CIPHER PHARMACEUTICALS SCHEDULES Q2 2026 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the second quarter of 2026 after the market close on Tuesday, Aug. 11, 2026. The company will also hold a conference call on Wednesday, Aug. 12, 2026, at 8:30 a.m. ET to discuss the results and corporate developments.

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the United States and South America.